Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
Part of paid clinical trials in Potsdam, New York.
- Sponsor
- St. Lawrence Health System
- Study ID
- NCT07034196
- Status
- Recruiting
Conditions
- Rheumatoid Arthritis (RA
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Primary Care Treatment in lieu of Rheumatologist — OTHERRA patients will be randomized to receive their RA care via their established PCP who completed a structured training course in RA and who has monthly case review/consultation sessions with the rheumatology team in this study
Study Details
Rheumatoid arthritis (RA) is a complex autoimmune disease where the immune system attacks healthy joint tissue; causing pain, swelling, and stiffness of the joints. This disease effects lots of people in the US and can lead to major joint damage if not properly treated. In rural areas like northern NY, these are underserved areas for RA patients, thus many patients struggle to get the appropriate care. This model is testing whether primary care providers (PCP) can safely and effectively provide stable RA patients with the proper treatment rather than send them to a specialist. PCPs were trained through classes, case reviews, and a final exam. Patients will be randomly assigned to either see a trained PCP or their normal rheumatologist at the rheumatology clinic. This study will examine how patients are doing over a year using medical exams and patient feedback. If this model proves to be successful, it will make RA treatment easier and more affordable for patients.
Key Dates
- Start date
- Jun 26, 2025
- Status verified
- Jun 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: Control Arm- Rheumatology ClinicianContinue with usual RA care in their rheumatologist's office
- Active Comparator: Intervention Arm- Primary Care ClinicianRA patients will be randomized to receive their RA care via their established PCP who completed a structured training course in RA and who has monthly case review/consultation sessions with the rheumatology team in this study
Primary Outcome Measure
Change in Disease Activity Score (DAS-28) [ Time Frame: 6 and 12 month intervals relative to baseline ]
Central Contacts
- McKailey Lyndaker315-261-6352
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| St. Lawrence Health | Potsdam | New York | 13676 | Eyal Kedar, MD (SUB_INVESTIGATOR) |
Find similar trials in Potsdam, NY
Related Studies
- Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-BeingRecruiting · Weill Medical College of Cornell University · New York, New York
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.PHASE2 · Recruiting · Artiva Biotherapeutics, Inc. · Tuscaloosa, Alabama
- Ultrasound Neuroimmune Modulation in Adults With Rheumatoid ArthritisPHASE2 · Recruiting · Surf Therapeutics · Colleyville, Texas
- The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) StudyRecruiting · Brigham and Women's Hospital · Boston, Massachusetts